Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
In a week-long burst of closings, six starter units priced at $90k-$140k sold, five via seller financing. The episode...
Bitcoin edges toward the long-term holder cost basis as on-chain data flags growing risk of capitulation. Analysts wa...
Goldman Sachs lowers its 12-month oil-price target to align with current market levels as traders weigh the prospects...
Tensions in the Middle East have traders eyeing crude prices. This article examines why analysts predict iran conflic...
As July 2 approaches, investors debate whether to buy Tesla stock ahead of the Q2 delivery data. This guide breaks do...
As 2026 retirement limits rise, owner-operators may qualify for a far larger Solo 401(k) than company drivers using a...
The federal debt breached $39 trillion this week as lawmakers debated a constitutional fix that failed to pass. The p...
As 2026 unfolds, the Social Security survivor program remains intricate. This report clarifies who actually qualifies...
A caller facing a $7,000 IRS bill on The Ramsey Show was urged to pay immediately to avoid steep penalties and daily-...
A troubling incident in Florida highlights not just cruelty but the real costs of pet emergencies. This guide outline...
Is Block stock a smart addition to your portfolio today? This guide ties Block's potential to tax advantaged investin...